Viewing Study NCT05691504


Ignite Creation Date: 2025-12-24 @ 9:18 PM
Ignite Modification Date: 2025-12-25 @ 7:05 PM
Study NCT ID: NCT05691504
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2023-01-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module